St. George's University of London, London, UK.
Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Vasc Endovascular Surg. 2025 Jan;59(1):64-75. doi: 10.1177/15385744231185606. Epub 2023 Jun 20.
Abdominal aortic aneurysm (AAA) has a prevalence of 4.8%. AAA rupture is associated with significant mortality, thus surgical intervention is generally required once the aneurysm diameter exceeds 5.5 cm. Endovascular aneurysm repair (EVAR) is the predominant repair modality for AAA. However, in patients with complex aortic anatomy, fenestrated or branched EVAR is a superior repair option vs standard EVAR. Fenestrated and branched endoprostheses can be off-the-shelf or custom-made, which offers a more individualised approach.
To summarise and evaluate the clinical outcomes achieved by fenestrated EVAR (FEVAR) and branched EVAR (BEVAR), and to explore the role of custom-made endoprostheses in contemporary AAA management.
A literature search using Ovid Medline and Google Scholar was conducted to identify literature pertaining to the use and outcomes of fenestrated, branched, fenestrated-branched and custom-made endoprostheses for AAA repair.
FEVAR is an effective repair modality for patients with AAA that offers similar early survival, improved early morbidity but higher rates of reintervention in comparison to open surgical repair (OSR). Compared with standard EVAR, FEVAR is associated with similar in-hospital mortality yet higher rates of morbidity, especially regarding renal outcomes. BEVAR outcomes are rarely reported exclusively in the context of AAA repair. When reported, BEVAR is an acceptable alternative to EVAR in the treatment of complex aortic aneurysms and has similar reported complication issues to FEVAR. Custom-made grafts are a good alternative treatment option for complex aneurysms where hostile aneurysm anatomy precludes the use of conventional EVAR and sufficient time is available for the manufacturing of such devices.
FEVAR offers a very effective treatment for patients with complex aortic anatomy and has been well-characterised over the past decade. RCTs and longer-term studies are desirable for unbiased comparison of non-standard EVAR modalities.
腹主动脉瘤(AAA)的患病率为 4.8%。AAA 破裂与显著的死亡率相关,因此一旦动脉瘤直径超过 5.5cm,通常需要进行手术干预。血管内动脉瘤修复(EVAR)是 AAA 的主要修复方式。然而,对于复杂主动脉解剖结构的患者,覆膜支架开窗或分支型 EVAR 是优于标准 EVAR 的修复选择。覆膜支架开窗和分支型内假体可以是现货的或定制的,这提供了更个体化的方法。
总结和评估覆膜支架开窗 EVAR(FEVAR)和分支型 EVAR(BEVAR)的临床结果,并探讨定制内假体在当代 AAA 管理中的作用。
使用 Ovid Medline 和 Google Scholar 进行文献检索,以确定与 AAA 修复中使用和结果相关的覆膜支架开窗、分支、覆膜支架开窗-分支和定制内假体的文献。
FEVAR 是一种有效的 AAA 修复方式,其早期生存率与开放手术修复(OSR)相似,早期发病率更低,但再干预率更高。与标准 EVAR 相比,FEVAR 的住院死亡率相似,但发病率更高,尤其是在肾功能方面。在 AAA 修复背景下很少单独报告 BEVAR 的结果。当报告时,BEVAR 是治疗复杂主动脉瘤的一种可接受的替代 EVAR 的方法,其并发症问题与 FEVAR 相似。定制移植物是复杂动脉瘤的一种很好的替代治疗选择,当敌对的动脉瘤解剖结构排除了使用常规 EVAR 的可能性,并且有足够的时间制造此类设备时。
FEVAR 为复杂主动脉解剖结构的患者提供了一种非常有效的治疗方法,在过去十年中已经得到了很好的描述。对于非标准 EVAR 方式的无偏比较,需要 RCT 和更长期的研究。